Home > Boards > US Listed > Medical - Equipment >

InspireMD, Inc. (NSPR)

NSPR RSS Feed
Add NSPR Price Alert      Hide Sticky   Hide Intro
Moderator: Longer Than Most
Search This Board: 
Last Post: 5/17/2019 6:52:31 AM - Followers: 79 - Board type: Free - Posts Today: 0

Great Europe-Patent News for NSPR (01.05.2017):
 https://register.epo.org/application?number=EP07827415

NSPR is still one of the Cheapest NYSE stocks based on the New BV & CV! The 10-Q confirms its 100% Debt-Free financial status which is the most important fundamental for a big board stock ! 

https://register.epo.org/application?number=EP07827415 
https://finance.yahoo.com/news/inspiremd-announces-distribution-agreement-cguard-113000992.html 
http://finance.yahoo.com/news/inspiremd-announces-distribution-agreement-cguard-110000931.html 
http://finance.yahoo.com/news/inspiremd-cguard-tm-embolic-prevention-133200180.html 
http://www.marketwatch.com/story/inspiremd-repays-term-note-ahead-of-schedule-2017-03-22?siteid=bigcharts&dist=bigcharts 


InspireMD was founded in 2005 with the purpose of creating a technology that could solve the problem of embolization in high risk vascular procedures. The company has grown to include a portfolio of embolic protection systems, which it both manufactures and commercializes.

Today, InspireMD is a global company headquartered in Boston, MA. InspireMD seeks to utilize its proprietary MicroNetTM technology to make its products the industry standard for embolic protection by providing a superior solution to the key clinical issues of vascular procedures.
 

Our Technology

MicroNetTM

The MicroNet is a bio-stable mesh woven from a single strand of 20 μm Polyethylene Terephthalate (PET). The MicroNet is designed to trap and seal thrombus and plaque against the vessel wall, preventing embolization.

MicroNetTM key features:

  • PET is a bio-stable synthetic fiber widely used in a variety of industries.
    Attached and secured to the proximal and the distal crowns of the stent.
    Does not alter the procedure as it expands with the stent.
    Pore size is typically between 150 – 180 µm. 
     

CGuard™

need for tapered version


Carotid Embolic Prevention System

The CGuardTM Embolic Prevention System (EPS) is designed to prevent peri-procedural and late embolization by trapping potential emboli against the arterial wall while maintaining excellent perfusion to the external carotid artery and branch vessels.

Product Details:

  • CGuard material: Nitinol
MicroNet material: Polyethylene Terephthalate (PET)
  • Easy to use RX (Rapid Exchange) delivery system
     

MGuard™

Improving Clinical Outcomes For STEMI Patients

The MGuardTM Embolic Protection System (EPS), integrated with MicroNetTM  (see Our Technology), is designed to trap and seal thrombus and ruptured plaque, prevent distal embolization and optimize flow.

While offering performance that is superior to standard STEMI therapy, MGuard requires no change in current physician practice – an important factor in time-critical settings.

 

Product Details:

  • MGuard material: Stainless Steel 316 
  • MicroNet material: Polyethylene Terephthalate (PET)

     

MGuard Prime™

Improving Clinical Outcomes For STEMI Patients

The MGuard PrimeTM Embolic Protection System (EPS), integrated with MicroNetTM  (see Our Technology), is designed to trap and seal thrombus and ruptured plaque, prevent distal embolization, and optimize flow, while ensuring excellent deliverabililty.

While offering performance that is superior to standard STEMI therapy, MGuard Prime requires no change in current physician practice – an important factor in time-critical settings.

 

Product Details:

  • MGuard Prime material: Cobalt Chromium (CoCr) L605

MicroNet material: Polyethylene Terephthalate (PET)
  • Superior flexibility and excellent deliverability

http://www.inspiremd.com/en/products/the-technology/
 

2017 News

Thursday23March 2017

InspireMD’s CGuard™ Carotid Embolic Prevention System to be Featured at ICCA Stroke 2017 in Moscow, Russia

BOSTON, MA—March 23, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS), neurovascular devices and thrombus management technologies, today announced that its…

Wednesday22March 2017

InspireMD Repays Term Note Ahead of Schedule

Tel Aviv—March 22, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced that…

Tuesday21March 2017

InspireMD Announces Distribution Agreement for CGuard™ EPS in Hong Kong

BOSTON, MA—March 21, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced it…

Monday20March 2017

InspireMD Announces CGuardTM Distribution Agreement for the Russian Federation

Tel Aviv—March 20, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced it…

Wednesday15March 2017

InspireMD Reports Continued Progress in the Transition of European Sales and Distribution

Announces Agreements with Leading Distributors in the Baltic States   BOSTON, MA—March 15, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS)…

Tuesday14March 2017

InspireMD Announces Closing of Public Offering of Approximately $6.8 Million

BOSTON, MA – March 14, 2017 – InspireMD, Inc. (NYSE MKT: NSPR) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices,…

Thursday09March 2017

InspireMD Announces Pricing of Public Offering of up to $7.5 Million

BOSTON, MA – March 9, 2017 – InspireMD, Inc. (NYSE MKT: NSPR) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices,…

Thursday16February 2017

InspireMD Provides Year End Business Update and Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2016

Transition from Exclusive Distribution Partner to Local Distributors and Internal Sales Strategy Validated by Strong Revenue Growth in Select Markets   BOSTON, MA—February 16, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS)…

Tuesday24January 2017

InspireMD’s CGuard™ Carotid Embolic Prevention System to be Featured at LINC 2017

PD Dr. Andrej Schmidt to perform live case transmission of carotid stent surgery utilizing CGuard™ BOSTON, MA– January 24, 2016 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a…

Contact Us

Thank you for your interest in InspireMD, please let us know how we can help you. You can contact us at info@inspiremd.com or 1-888-776-6804.

Executives

James J. BarryPresident & Chief Executive Officer

Dr. Barry has over 20 years of experience in the medical device industry. Prior to joining InspireMD, he was the President and CEO of Arsenal Medical, a life sciences company…

Craig ShoreChief Financial Officer

Mr. Shore has over 25 years of experience in financial management in the United States, Europe and Israel. He has served in various senior financial and general management roles at…

Agustin GagoExecutive Vice President and Chief Commercial Officer

Mr. Gago has over 25 years of experience in building profitable international commercial, sales and marketing organizations. Prior to joining InspireMD, he was the founder and principal of Dash International…

Benzi SpectorHead of R&D and Operations

Mr. Spector has more than 25 years of experience in research, development and engineering, serving as the lead on a range of product lines and systems in the healthcare space….

Sharon ShacharHead of Regulatory and Quality

Mrs. Shachar has over 12 years of experience in quality, regulatory and clinical execution, serving in executive roles in small and large medical companies.   Prior to joining InspireMD, she…

Website:  http://www.inspiremd.com/en/

 

NSPR
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#2144  Sticky Note Ran to $5 so quickly because so many Longer Than Most 05/01/19 12:37:49 PM
#2166   Strong buy: Inspire burned money for many years. Bernardo75 05/17/19 06:52:31 AM
#2165   NSPR ist a very speculative strong buy. No Bernardo75 05/17/19 06:47:26 AM
#2164   I call them today and my phone call cash_cow1 05/15/19 09:53:40 PM
#2163   Definitely need something now. It's 1/2 of the Three2001 05/15/19 04:26:50 PM
#2162   Would had a great ER if the equipment cash_cow1 05/15/19 03:52:28 PM
#2161   My expectation is that ER is going to cash_cow1 05/13/19 08:46:33 PM
#2160   What are the expectations on earnings? Longer Than Most 05/13/19 11:30:58 AM
#2158   Let's see $5 set-up for Monday to run cash_cow1 05/10/19 10:11:12 AM
#2157   InspireMD, Inc. (NSPR) stock could soar today on cash_cow1 05/09/19 08:34:12 AM
#2156   I can't believe NSPR fell below $5 today. cash_cow1 05/08/19 09:13:33 PM
#2155   Good earnings would cause a hilarious squeeze $NSPR Longer Than Most 05/08/19 01:47:37 PM
#2154   Earnings next Tuesday. And they better blow everyone Three2001 05/08/19 11:49:45 AM
#2153   Earnings Report due next Monday May 6th. cash_cow1 05/03/19 09:20:29 AM
#2152   Good the Robin Hood Crew is leaving for cash_cow1 05/02/19 06:01:16 PM
#2151   I call $10+ yesterday for ABIO and it cash_cow1 05/02/19 05:59:19 PM
#2150   News and we're off to the races. cash_cow1 05/02/19 05:52:59 PM
#2149   Yes is matter of time . Stock needs Explorergypsy1 05/02/19 10:08:42 AM
#2148   Squeeezzzzeeeee. Shorts have had such a great time Longer Than Most 05/02/19 09:48:30 AM
#2147   Nutty volume. Sponsoring Thought 05/02/19 09:42:31 AM
#2146   Good insight. It is back to where it dipbuy 05/01/19 07:24:51 PM
#2145   Nice. dipbuy 05/01/19 06:13:31 PM
#2144   Ran to $5 so quickly because so many Longer Than Most 05/01/19 12:37:49 PM
#2143   $5 again, will it hold? Any reason for Three2001 04/29/19 03:49:46 PM
#2142   Anything but a pump here. They put out Three2001 04/25/19 05:47:43 PM
#2141   was a pump over $5.40 wilburb 04/25/19 05:02:04 PM
#2140   Plus volume is drying up significantly. Doesn’t play Longer Than Most 04/25/19 10:18:01 AM
#2139   Around 50% of the OS is short. $NSPR Longer Than Most 04/25/19 10:09:30 AM
#2138   If $NSPR can start pushing north of $5 Longer Than Most 04/17/19 12:16:44 PM
#2137   What classifies it as “technically” being a Longer Than Most 04/16/19 07:37:56 PM
#2136   well, Technically........ NSPR is being wilburb 04/16/19 06:37:26 PM
#2135   It’s called technicals....I mentioned nothing about news Longer Than Most 04/16/19 06:20:57 PM
#2134   NSPR is being pumped on a wilburb 04/16/19 05:38:18 PM
#2133   AH could be a doozy! $NSPR Longer Than Most 04/16/19 03:57:50 PM
#2132   AH might be fun yankees18 04/16/19 03:52:22 PM
#2131   A third entity has filed for ownership of Three2001 04/12/19 12:40:09 PM
#2130   long aristotelisonassis 04/11/19 03:08:36 PM
#2129   Watching? $NSPR Longer Than Most 04/08/19 03:20:48 PM
#2128   Watch this bro Longer Than Most 04/08/19 02:20:46 PM
#2127   Nhod Longer Than Most 04/08/19 02:20:28 PM
#2126   One word... SABBY! Timber.... 420man 04/08/19 01:04:12 PM
#2125   You know the offering is only for ~500K Longer Than Most 04/08/19 12:08:58 PM
#2124   No way! It will take at least a Value_Investor 04/07/19 05:43:09 PM
#2123   Public offering probably going to close out soon... Longer Than Most 04/05/19 07:34:25 PM
#2122   Ive decided not to touch this stock ever 420man 04/05/19 06:19:32 PM
#2121   Another New low $4.01 was created yesterday! We Value_Investor 04/05/19 04:07:50 PM
#2120   That's only a 10% gain if one happens 420man 04/05/19 08:02:27 AM
#2119   News: $NSPR InspireMD, Inc. Announces Pricing of $2.4 whytestocks 04/04/19 08:00:34 AM
#2118   The Pos Scam already crashed to $4. 5 in Value_Investor 04/03/19 08:56:52 PM
#2117   They are literally surviving off of retail! Yes, 420man 04/03/19 05:16:40 PM
#2116   No sh!t! Made a nice gain today back Three2001 04/03/19 05:08:01 PM
PostSubject